搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Everyday Health
4 天
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets FDA Approval
Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...
The Asian Parent on MSN
8 天
Atopic Dermatitis in Kids: What Every Parent Should Know
Don’t let eczema control your child's life! Discover expert tips on managing atopic dermatitis for a happier, itch-free ...
Lianhe Zaobao
13 天
止不住的瘙痒 异位性皮肤炎怎么控制?
异位性皮肤炎不仅会伤害患者的皮肤,也可能影响生活质量和日常活动。新加坡中央医院将在9月13日(星期五)举办“异位性皮肤炎——不止是皮肤表层问题”(Atopic Dermatitis – More than skin deep?)线上英语讲座。
The Pharma Letter
3 天
Atopic dermatitis market set for major growth
The atopic dermatitis (AD) market is projected to reach $16.7 billion by 2030, according to GlobalData. New therapies like ...
3 天
on MSN
FDA Approves New Biologic Treatment For Atopic Dermatitis, Know How It Can Help Achieve ...
The FDA has approved Ebglyss (lebrikizumab-lbkz), a new biologic treatment for moderate-to-severe atopic dermatitis in people ...
1 天
This Redness-Reducing Facial Spray Is More Essential Than My Moisturizer
Dermatologists explain how hypochlorous acid can treat redness and acne, and suggest some more products that use it.
3 天
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
The U.S. Food and Drug Administration has approved Eli Lilly's Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 ...
Daily
3 天
Cord Blood Levels of IL-31 and CCL17 and cutaneous markers may predict Atopic Dermatitis ...
Researchers investigated the correlation between serum levels of interleukin-31 (IL-31) and CCL17, as well as cutaneous ...
FiercePharma
4 天
Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama
Atopic dermatitis, for its part, affects roughly 16.5 million adults and 9.6 million children in the U.S. According to ...
2 天
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Organon acquires ROIV's Dermavant for $1.2B, expanding their dermatology portfolio and potentially increasing sales. Click ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈